Literature DB >> 21755260

Prevalence of metabolic syndrome and its association with educational inequalities among Brazilian adults: a population-based study.

M F Gronner1, P L Bosi, A M Carvalho, G Casale, D Contrera, M A Pereira, T M Diogo, M T C G Torquato, G M D Souza, J Oishi, A M O Leal.   

Abstract

The present study estimated the prevalence of metabolic syndrome (MS) according to the criteria established by the National Cholesterol Education Program-Adult Treatment Panel III (NCEP-ATPIII) and the International Diabetes Federation (IDF) and analyzed the contribution of social factors in an adult urban population in the Southeastern region of Brazil. The sample plan was based on multistage probability sampling according to family head income and educational level. A random sample of 1116 subjects aged 30 to 79 years was studied. Participants answered a questionnaire about socio-demographic variables and medical history. Fasting capillary glucose (FCG), total cholesterol, high-density lipoprotein cholesterol (HDL-C), and triglycerides were determined and all non-diabetic subjects were submitted to the 75-g oral glucose tolerance test. Body mass index (BMI, kg/m(2)), waist circumference and blood pressure (BP) were determined. Age- and gender-adjusted prevalence of MS was 35.9 and 43.2% according to NCEP-ATPIII and IDF criteria, respectively. Substantial agreement was found between NCEP-ATPIII and IDF definitions. Low HDL-C levels and high BP were the most prevalent MS components according to NCEP-ATPIII criteria (76.3 and 59.2%, respectively). Considering the diagnostic criteria adopted, 13.5% of the subjects had diabetes and 9.7% had FCG ≥100 mg/dL. MS prevalence was significantly associated with age, skin color, BMI, and educational level. This cross-sectional population-based study in the Southeastern region of Brazil indicates that MS is highly prevalent and associated with an important social indicator, i.e., educational level. This result suggests that in developing countries health policy planning to reduce the risk of MS, in particular, should consider improvement in education.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21755260     DOI: 10.1590/s0100-879x2011007500087

Source DB:  PubMed          Journal:  Braz J Med Biol Res        ISSN: 0100-879X            Impact factor:   2.590


  11 in total

1.  Relationship Between Metabolic Syndrome and the Brazilian Workers' Food Program in Male and Female Manufacturing Workers.

Authors:  Gabriela Santana Pereira; Ingrid Wilza Leal Bezerra; Anissa Melo de Souza; Isabelle Cristina Clemente Dos Santos; Vivian Nogueira Silbiger; Raiane Medeiros Costa; Karina Gomes Torres; Antonio Gouveia Oliveira
Journal:  Diabetes Metab Syndr Obes       Date:  2020-10-13       Impact factor: 3.168

Review 2.  Prevalence of metabolic syndrome in Brazilian adults: a systematic review.

Authors:  Fernanda de Carvalho Vidigal; Josefina Bressan; Nancy Babio; Jordi Salas-Salvadó
Journal:  BMC Public Health       Date:  2013-12-18       Impact factor: 3.295

3.  Prevalence of metabolic syndrome: association with risk factors and cardiovascular complications in an urban population.

Authors:  Gisela Cipullo Moreira; José Paulo Cipullo; Luiz Alberto Souza Ciorlia; Cláudia Bernardi Cesarino; José Fernando Vilela-Martin
Journal:  PLoS One       Date:  2014-09-02       Impact factor: 3.240

4.  Hypertension, diabetes and obesity are associated with lower cognitive performance in community-dwelling elderly: Data from the FIBRA study.

Authors:  Monalisa Fernanda Bocchi de Oliveira; Mônica Sanches Yassuda; Ivan Aprahamian; Anita Liberalesso Neri; Maria Elena Guariento
Journal:  Dement Neuropsychol       Date:  2017 Oct-Dec

5.  Diagnostic Yield and Accuracy of Different Metabolic Syndrome Criteria in Adult Patients with Epilepsy.

Authors:  Lucas Scotta Cabral; Pedro Abrahim Cherubini; Marina Amaral de Oliveira; Larissa Bianchini; Carolina Machado Torres; Marino Muxfeldt Bianchin
Journal:  Front Neurol       Date:  2017-09-01       Impact factor: 4.003

6.  Prevalence of the metabolic syndrome according to different criteria in the male population during the Blue November Campaign in Natal, RN, Northeastern Brazil.

Authors:  Regina Carmen Espósito; Paulo Jose de Medeiros; Fernando de Souza Silva; Antonio Gouveia Oliveira; Cícero Flávio Soares Aragão; Hugo Alexandre Oliveira Rocha; Sueli Aparecida Moreira; Valéria Soraya de Farias Sales
Journal:  Diabetes Metab Syndr Obes       Date:  2018-08-06       Impact factor: 3.168

7.  Adiponectin: An Indicator for Metabolic Syndrome.

Authors:  Somaye Yosaee; Mahmoud Khodadost; Alireza Esteghamati; John R Speakman; Kurosh Djafarian; Vida Bitarafan; Farzad Shidfar
Journal:  Iran J Public Health       Date:  2019-06       Impact factor: 1.429

8.  Predictors of Metabolic Syndrome in Adults and Older Adults from Amazonas, Brazil.

Authors:  Élvio Rúbio Gouveia; Bruna R Gouveia; Adilson Marques; Miguel Peralta; Cíntia França; Alex Lima; Alderlane Campos; Jefferson Jurema; Matthias Kliegel; Andreas Ihle
Journal:  Int J Environ Res Public Health       Date:  2021-02-01       Impact factor: 3.390

9.  Comparison of salivary and plasma adiponectin and leptin in patients with metabolic syndrome.

Authors:  Supanee Thanakun; Hisashi Watanabe; Sroisiri Thaweboon; Yuichi Izumi
Journal:  Diabetol Metab Syndr       Date:  2014-02-14       Impact factor: 3.320

10.  Metabolic syndrome, C-reactive protein and cardiovascular risk in psoriasis patients: a cross-sectional study.

Authors:  Renato Soriani Paschoal; Daniela Antoniali Silva; Renata Nahas Cardili; Cacilda da Silva Souza
Journal:  An Bras Dermatol       Date:  2018-03       Impact factor: 1.896

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.